EP.12H.05 Phase II Study on Platinum-Pemetrexed and Lorlatinib Combination in ALK-Positive NSCLC Extracranially Progressing on Lorlatinib.

Autor: Bertoli, E., Da Carlo, E., Del Conte, A., Stanzione, B., Montico, M., Mazzoni, F., Camerini, A., Cortinovis, D., Delmonte, A., Metro, G., Pasello, G., Pelizzari, G., Tiseo, M., Battistuzzi, T., Bearz, A.

Publikováno v: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS658-S659, 2p

Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

Autor: Salton F., Confalonieri P., Centanni S., Mondoni M., Petrosillo N., Bonfanti P., Lapadula G., Lacedonia D., Voza A., Carpene N., Montico M., Reccardini N., Meduri G. U., Ruaro B., Confalonieri M., Citton G. M., Bozzi C., Tavano S., Pozzan R., Andrisano A. G., Jaber M., Mari M., Trotta L., Mondini L., Barbieri M., Ruggero L., Antonaglia C., Soave S., Torregiani C., Bogatec T., Baccelli A., Nalesso G., Re B., Pavesi S., Barbaro M. P. F., Giuliani A., Ravaglia C., Poletti V., Scala R., Guidelli L., Golfi N., Vianello A., Achille A., Lucernoni P., Gaccione A. T., Romagnoli M., Fraccaro A., Malacchini N., Malerba M., Ragnoli B., Zamparelli A. S., Bocchino M., Blasi F., Spotti M., Miele C., Piedepalumbo F., Barone I., Baglioni S., Dodaj M., Franco C., Andrani F., Mangia A., Mancini A., Carrozzi L., Rafanelli A., Casto E., Rogliani P., Ora J., Carpagnano G. E., Di Lecce V., Tamburrini M., Papi A., Contoli M., Luzzati R., Zatta M., Di Bella S., Caraffa E., Francisci D., Tosti A., Pallotto C., De Rosa F. G., Pecori A., Franceschini M., Carlin M., Orsini V., Pollastri E., Rugova A., Sabbatini F., Soria A., Rossi M., Santantonio T., Meli R., Sauro S., Fedeli C., Mangini E., Biolo G., Nunnari A., Pietrangelo A., Corradini E., Bocchi D., Boarini C., Zucchetto A., Lanini S.

BackgroundDysregulated systemic inflammation is the primary driver of mortality in severe coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7–10-day course of any glucocorticoid equivalent to dexamethasone 6 mg daily. A com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f38d55d1755a2ae500d27a3ca2b858
https://hdl.handle.net/2434/949516

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy

Autor: Cangemi, M., Montico, M., Trovo, M., Minatel, E., Di Gregorio, E., Corona, G., Giordari, F., Comaro, E., Colizzi, F., Baboci, L., Steffan, A., Revelant, A., Muraro, E.

Publikováno v: International journal of radiation oncology, biology, physics.

The present study aimed at evaluating the baseline immune profile and the immunomodulating effects of radical hemithoracic radiation therapy (RT) in patients affected by malignant pleural mesothelioma (MPM) to identify potential predictive biomarkers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb7e655e21247001c6441e6609eca9c
https://pubmed.ncbi.nlm.nih.gov/36202181

Atypical onset as predictor of poor outcome in Pediatric Systemic Lupus Erythematosus (pSLE)

Autor: Taddio A, Rossetto E, Lepore L, Brescia AC, Bracaglia C, Caminiti S, Cortis E, Rigante D, Stabile A, Montico M, Ronfani L, Rosé CD

Publikováno v: Pediatric Rheumatology Online Journal, Vol 6, Iss Suppl 1, p P238 (2008)

Externí odkaz: https://doaj.org/article/c4370a603aad4c6d99163ea46816c7ca